Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAHCC1 encodes a protein with a BAH (bromo-adjacent homology) domain and coiled-coil motifs, implicated in chromatin binding and organization. It acts upstream of biological processes including neuron differentiation and locomotory behavior, but is not established as a therapeutic target. The gene is associated with chromatin organization and has connections to KBG syndrome. Its molecular function relates principally to regulation of chromatin dynamics rather than canonical receptor or enzyme activity. The query target "ENSG00000306930" does not correspond to any recognized entity; BAHCC1 is canonical, but not as a therapeutic target. The provided abbreviation "ENSG00000306930" does not exist in Ensembl or other genomic repositories; the correct Ensembl ID for BAHCC1 is "ENSG00000266074". The phrase "novel transcript, sense intronic to BAHCC1" likely refers to an uncharacterized or predicted transcript overlapping BAHCC1, with no established role or recognition in authoritative databases. BAHCC1 is not a canonical therapeutic target and the specified transcript and abbreviation are not recognized entities in current databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAH domain and coiled-coil containing 1 (BAHCC1).